Financials

  • Market Capitalization 386.03 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.51
Rapporto prezzo/fatturato
8.81

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3009
MPLT
MapLight Therapeutics, Inc. - Common Stock
8.60 USD-2.60%-6.93%-34.25%-54.74%398.85 M USD
3024
GALT
Galectin Therapeutics Inc. - Common Stock
3.87 USD-1.78%+3.20%-2.03%-24.56%390.29 M USD
3031
KYTX
Kyverna Therapeutics, Inc. - Common Stock
6.21 USD-2.82%-2.66%-14.34%-7.04%384.05 M USD
3034
ZURA
Zura Bio Limited - Class A Ordinary shares
4.00 USD0.00%+0.76%-23.22%+6.10%383.32 M USD